SinterCast

SinterCast

Sälj aktien Köp aktien Handla aktien direkt på nordnet

« Tillbaka

SinterCast - Market weakness and FX still major headwinds

27 januari 2026

  • We forecast sales -27% y-o-y, driven by EEs -13% and FX -9%
  • Substantial market weakness, tough comps & FX headwinds in '25e
  • Pent-up demand, programme starts & installations bode well for '26e

Q4 expectations

With the automotive market still experiencing demand challenges, we expect engine equivalent production of 2.7m, in line with Q3 but down 13% y-o-y. We forecast strong installation revenue of SEK 4.9m, bringing the full-year figure to SEK 10m as guided for by the company, but this faces even stronger comps of SEK 6.8m. All-in-all we estimate a 27% decline in revenue y-o-y, with the weakening USD constituting a 9% headwind. With the cost base largely unchanged and an estimated margin effect from hedges of +2.2pp (-6.3pp), this results in an EBIT margin of 20.9% (26.5%).

Estimate changes

We cut '26e-'27e sales by 6% and EBIT by 11-12%, almost exclusively driven by the weakened USD/SEK exchange rate.

Outlook and valuation

2025 was a year of substantial market headwinds and tough comps, given the production programme that reached end of life in Q3'24, amplified further by the drastically weakened USD vs. the SEK, as all of SinterCast's sales are USD denominated; however, pent-up demand for truck fleet renewal as well as delayed programme starts and strong installation activity bode well for a return to growth in 2026e. We forecast EPS growth of 16% and 32% over the coming two years, leaving the company trading at P/E 24-18x on '26e-'27e.

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-03-12 StrongPoint - Investor update StrongPoint Analys
2026-03-08 Medicover - From build-out to fill-up Medicover Analys
2026-03-02 Qben Infra - Portfolio reshaping continues Qben Infra Analys
2026-02-27 Xplora Technologies - Record quarter driven by Se... Xplora Tech.. Analys
2026-02-24 Isofol Medical - From first lessons to second exe... Isofol Medical Analys
2026-02-24 B3 Consulting Group - Cost adjustments should lif... B3 Consulti.. Analys
2026-02-23 Ework Group - Market conditions yet to improve Ework Group Analys
2026-02-23 Formpipe - Good margins, but ACV lags Formpipe Analys
2026-02-23 Energy Save - Back to growth, but softer H1'26 ex... Energy Save Analys
2026-02-23 Fastpartner - Outlook taking a hit Fastpartner Analys
2026-02-23 Cavotec - Industry shines in cautious environment Cavotec Analys
2026-02-20 Arctic Paper - Still challenging Arctic Paper Analys
2026-02-20 Inission - Set for substantial earnings growth Inission Analys
2026-02-20 BTS Group - Ahead of plan on growth recovery BTS Group Analys
2026-02-20 Energy Save - OEM sales up, softer start to '26 e... Energy Save Analys
2026-02-20 Formpipe - Weaker ACV, but higher dividends Formpipe Analys
2026-02-20 B3 Consulting Group - Margin beat on cost cuts B3 Consulti.. Analys
2026-02-20 BTS Group - North America behind Q4 miss BTS Group Analys
2026-02-20 Skolon - Q4'25 momentum to also pay off in H1'26 Skolon Analys
2026-02-20 Ogunsen - Easier comps await in '26e Ogunsen Analys